Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases

Peroxisome proliferator activated receptor (PPAR)-γ is a nuclear hormone receptor that is activated by multiple agonists including thiazolidinediones, prostaglandins, and synthetic oleanolic acids. Many PPARγ ligands are under investigation as potential therapies for human diseases. These ligands mo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ajit A. Kulkarni, Collynn F. Woeller, Thomas H. Thatcher, Sesquile Ramon, Richard P. Phipps, Patricia J. Sime
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	PPAR Research
Online Access:	http://dx.doi.org/10.1155/2012/705352
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of PPARs in Lung Fibrosis
by: Heather F. Lakatos, et al.
Published: (2007-01-01)

PPARγ and the Innate Immune System Mediate the Resolution of Inflammation
by: Amanda Croasdell, et al.
Published: (2015-01-01)

Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes
by: P. J. Simpson-Haidaris, et al.
Published: (2010-01-01)

The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination
by: Graham Skelhorne-Gross, et al.
Published: (2012-01-01)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
by: Robert I. Glazer, et al.
Published: (2008-01-01)

PPARγ as a Novel Therapeutic Target in Lung Cancer
by: Aravind T. Reddy, et al.
Published: (2016-01-01)

PPARγ and Its Role in Cardiovascular Diseases
by: Mini Chandra, et al.
Published: (2017-01-01)

Thiazolidinediones on PPARγ: The Roles in Bone Remodeling
by: Wei Wei, et al.
Published: (2011-01-01)

PPARγ in Inflammatory Bowel Disease
by: Vito Annese, et al.
Published: (2012-01-01)

PPARγ Signaling Mediates the Evolution, Development, Homeostasis, and Repair of the Lung
by: Virender K. Rehan, et al.
Published: (2012-01-01)

The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
by: Tamotsu Tsukahara
Published: (2012-01-01)

PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia
by: Sarawin Harnchoowong, et al.
Published: (2017-01-01)

Therapeutic Implications of PPARγ in Cardiovascular Diseases
by: Hiroshi Hasegawa, et al.
Published: (2010-01-01)

Resolving the Two “Bony” Faces of PPAR-γ
by: Beata Lecka-Czernik, et al.
Published: (2006-01-01)

Therapeutic Implications of PPARγ in Human Osteosarcoma
by: Eric R. Wagner, et al.
Published: (2010-01-01)

The Model of PPARγ-Downregulated Signaling in Psoriasis
by: Vladimir Sobolev, et al.
Published: (2020-01-01)

The Role of PPARγ in Helicobacter pylori Infection and Gastric Carcinogenesis
by: Jong-Min Lee, et al.
Published: (2012-01-01)

PPARγ Ligands Regulate Noncontractile and Contractile Functions of Airway Smooth Muscle: Implications for Asthma Therapy
by: Chantal Donovan, et al.
Published: (2012-01-01)

To Live or to Die: Prosurvival Activity of PPARγ in Cancers
by: Y. Lynn Wang, et al.
Published: (2008-01-01)

PPAR-γ Signaling Crosstalk in Mesenchymal Stem Cells
by: Ichiro Takada, et al.
Published: (2010-01-01)

Fine-Tuning Reception in the Bone: PPARγ and Company
by: Z. Elizabeth Floyd, et al.
Published: (2006-01-01)

PPARγ and Its Agonists in Chronic Kidney Disease
by: Yuhua Ma, et al.
Published: (2020-01-01)

Identification of Bexarotene as a PPARγ Antagonist with HDX
by: David P. Marciano, et al.
Published: (2015-01-01)

PPARγ in Bacterial Infections: A Friend or Foe?
by: Aravind T. Reddy, et al.
Published: (2016-01-01)

Protective Actions of PPAR-γ Activation in Renal Endothelium
by: Peter E. Westerweel, et al.
Published: (2008-01-01)

The Role of the PAX8/PPARγ Fusion Oncogene in Thyroid Cancer
by: Kimberly A. Placzkowski, et al.
Published: (2008-01-01)

A Role for PPARγ in the Regulation of Cytokines in Immune Cells and Cancer
by: Xiao Yi Yang, et al.
Published: (2008-01-01)

The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects
by: Galina S. Bogatkevich, et al.
Published: (2012-01-01)

Review of the Structural and Dynamic Mechanisms of PPARγ Partial Agonism
by: Alice J. Kroker, et al.
Published: (2015-01-01)

Solution Structures of PPARγ2/RXRα Complexes
by: Judit Osz, et al.
Published: (2012-01-01)

New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
by: Zhanjun Jia, et al.
Published: (2014-01-01)

Anti- and Protumorigenic Effects of PPARγ in Lung Cancer Progression: A Double-Edged Sword
by: Howard Li, et al.
Published: (2012-01-01)

PPARγ Expression and Function in Mycobacterial Infection: Roles in Lipid Metabolism, Immunity, and Bacterial Killing
by: Patricia E. Almeida, et al.
Published: (2012-01-01)

Rosiglitazone, a Ligand to PPARγ, Improves Blood Pressure and Vascular Function through Renin-Angiotensin System Regulation
by: María Sánchez-Aguilar, et al.
Published: (2019-01-01)

Homocysteine and Hypertension in Diabetes: Does PPARγ Have a Regulatory Role?
by: Utpal Sen, et al.
Published: (2010-01-01)

The Modulation of PPARγ1 and PPARγ2 mRNA Expression by Ciglitazone in CD3/CD28-Activated Naïve and Memory CD4+ T Cells
by: Mohd Nor Norazmi, et al.
Published: (2012-01-01)

The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria
by: Lena Serghides
Published: (2012-01-01)

PPAR-γ Regulates Trophoblast Differentiation in the BeWo Cell Model
by: Khrystyna Levytska, et al.
Published: (2014-01-01)

Structural Features and Transcriptional Activity of Chicken PPARs (α, β, and γ)
by: Ichiro Takada, et al.
Published: (2013-01-01)

Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer
by: Sakshi Sikka, et al.
Published: (2012-01-01)